Sign inJoin waitlistJoin the waitlist

Orin Bloch

Director, UC Davis Brain Tumor Program · University of California Davis Health

Credentials: · · · ·

History

University of California Davis Health
Present

Allergy and Immunology
University of California-San Francisco
2012–2013
Neurological Surgery
University of California (San Francisco) School of Medicine
2007–2012
General Surgery
University of California-San Francisco
2006–2007
Univ of California, San Francisco Sch of Med
2002–2006
Bioengineering, University of Pennsylvania, Philadelphia PA
1997–2001

Research

Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages
Clinical Cancer Research · 2013 · First of 6 authors · 385 citations
Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article
Journal of neurosurgery · 2012 · First of 8 authors · 339 citations
A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma
Science Translational Medicine · 2021 · 265 citations

AP
Andrew Parsa
61 papers
Michael Safaee
22 papers · 12 as a resident
Taemin Oh
22 papers · 6 as a resident
Matthew Sun
21 papers · 4 as a resident
GK
Gurvinder Kaur
19 papers · 15 as a resident
ES
Eli Sayegh
16 papers · 3 as a resident
Jonathan Lamano
15 papers · 1 as a resident
Aaron Clark
12 papers · 12 as a resident
Michael Ivan
12 papers · 12 as a resident
Michael McDermott
12 papers
LA
Leonel Ampie
10 papers · 3 as a resident
MS
Michael Sughrue
10 papers · 9 as a resident

Grants

Integration of 5-ALA Fluorescence Lifetime Imaging with Stereotactic Surgical Navigation for Quantitative Real-Time Spatial Localization of Tumor During Neurosurgical Procedures
National Cancer Institute · R01
Contact PI · $2.2M · University of California at Davis
2023–2027
Label-Free Fluorescence Lifetime Imaging for Intraoperative Real-Time Guidance of Neurological Procedures
National Cancer Institute · R01
PI · $3M · University of California at Davis
2020–2026
Fluorescence Lifetime Technique for Intraoperative Identification of IDH Mutations in Brain Cancer
National Cancer Institute · R21
PI · $386.6K · University of California at Davis
2020–2023
B7H1 Mediated Immunosuppression in Glioma
National Cancer Institute · R01
Contact PI · $971.5K · University of California at Davis
2013–2020

Clinical trials

Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
Study chair · Terminated · Phase 2
Alliance for Clinical Trials in Oncology
2013–2023